Diagnostics
News and analysis on diagnostic technologies and applications.
ESR1 Mutation Testing May be Informative for Personalizing SERD Treatment, SABCS Studies Show
Premium
In two studies, testing for ESR1 mutations identified patients who responded particularly well to SERDs.
Freenome Raises $300M in Series D Financing
The company will use the funding to support commercialization of its blood-based colorectal cancer detection test and to fuel expansion to other tumor types.
NGM Biopharmaceuticals, Merck to Study ILT2/4 Inhibitor Plus Keytruda in Solid Tumors
The companies inked a collaboration to study the drug combination in advanced solid tumors with elevated expression of ILT2 and ILT4.
Redx Pharma, Caris Life Sciences Partner for Colorectal Cancer Phase II Drug Study Recruitment
The pharma firm is using Caris’ comprehensive molecular profiling to help advance its investigational Porcupine inhibitor, RXC004, in the US.
Kronos Bio Begins Enrollment in Phase III Trial of Entospletinib in NPM1-Mutated AML
The company may seek accelerated approval of its SYK inhibitor with chemo based on results from the AGILITY trial, which are expected in 2023.